Genmab

Latest news

• Genmab A/S Stock 12‑Month Price Target Raised to $39.57, Implies 15% Upside (opens in a new tab)

  TradingView · Oct 2, 2026

• Merus leaves Nasdaq after Genmab deal: what it means for Merus stock (opens in a new tab)

  AD HOC NEWS · Oct 2, 2026

• Precision Trading with Genmab A/s (GMAB) Risk Zones (opens in a new tab)

  Stock Traders Daily · Oct 1, 2026

• HC Wainwright keeps Buy on Genmab stock at USD 40 target (opens in a new tab)

  AD HOC NEWS · Oct 1, 2026

• MRUS stock ends after Genmab completes its acquisition (opens in a new tab)

  AD HOC NEWS · Sep 30, 2026

• Genmab Updates Capital Structure and Articles of Association in September 2026 SEC Filing (opens in a new tab)

  TipRanks · Sep 29, 2026

• Do Three Phase III Readouts Change The Bull Case For Genmab Stock? (opens in a new tab)

  Simply Wall Street · Sep 29, 2026

• Genmab stock reflects higher 2026 revenue guidance (opens in a new tab)

  AD HOC NEWS · Sep 29, 2026

• Genmab stock last trades at DKK 2,282.00 on September 28, 2026 (opens in a new tab)

  AD HOC NEWS · Sep 28, 2026

• Genmab (CPSE:GMAB) Nears Three Phase III Readouts, Is It Still Undervalued? (opens in a new tab)

  Simply Wall Street · Sep 27, 2026

• Genmab stock at DKK 2,277 on September 25, 2026, up 0.40 percent (opens in a new tab)

  AD HOC NEWS · Sep 26, 2026

• Genmab Grants New Employee Restricted Stock Units and Warrants (opens in a new tab)

  The Globe and Mail · Sep 25, 2026

• Genmab stock gains 0.8 percent ahead of the open (opens in a new tab)

  AD HOC NEWS · Sep 25, 2026

• Employees at Genmab (GMAB) receive free share awards and rights to buy shares at DKK 2,268. (opens in a new tab)

  Stock Titan · Sep 24, 2026

• Grant of Restricted Stock Units and Warrants to Employees in Genmab (opens in a new tab)

  GlobeNewswire · Sep 24, 2026

• Genmab (CPSE:GMAB) Stock Sees Modest Fair Value Cut As Analysts Weigh Pipeline Risks (opens in a new tab)

  Yahoo Finance · Sep 24, 2026

• Genmab A/S (GMAB) 10K Form and Latest SEC Filings 2026 (opens in a new tab)

  marketbeat.com · Sep 24, 2026

• Genmab stock heads into the open after a 0.84 percent gain (opens in a new tab)

  AD HOC NEWS · Sep 24, 2026

• Genmab AS stock hits 52-week high at 35.48 USD (opens in a new tab)

  Investing.com · Sep 23, 2026

• Genmab (CPSE:GMAB) Stock Looks Fairly Valued Following Its 25% Gain (opens in a new tab)

  Simply Wall Street · Sep 23, 2026

• Genmab at bank of america global healthcare conference: late-stage push (opens in a new tab)

  Investing.com · Sep 22, 2026

• Genmab stock advances as Q4 readouts stay on track (opens in a new tab)

  AD HOC NEWS · Sep 22, 2026

• (GMAB) Volatility Zones as Tactical Triggers (opens in a new tab)

  Stock Traders Daily · Sep 21, 2026

• Genmab stock holds steady after first-half 2026 earnings update (opens in a new tab)

  AD HOC NEWS · Sep 20, 2026

• Genmab stock heads into the open after a modest gain (opens in a new tab)

  AD HOC NEWS · Sep 18, 2026

• Genmab stock gains as HC Wainwright lifts Q3 earnings estimates and Phase 3 petosemtamab trial begin (opens in a new tab)

  AD HOC NEWS · Sep 17, 2026

• Genmab stock heads into the open after a 1.6% gain in Copenhagen (opens in a new tab)

  AD HOC NEWS · Sep 16, 2026

• Genmab stock gains as HC Wainwright lifts earnings estimates and confirms Buy rating (opens in a new tab)

  AD HOC NEWS · Sep 16, 2026

• Genmab at Morgan Stanley conference: pipeline widens, data loom (opens in a new tab)

  Investing.com · Sep 15, 2026

• Genmab (CPSE:GMAB) Could Be 15% Undervalued After Its Recent Rebound (opens in a new tab)

  Simply Wall Street · Sep 11, 2026